Cochrane Review Group

Stroke

108 systematic reviews in Stroke ask 1,248 questions. 22% have no studies to answer them, 21.6% rest on very low certainty evidence and 24% reach moderate or high certainty.

Reviews
108
Questions
1,248
current versions
No studies
22%
Moderate or high
24%
No studies 275 · 22%Ungraded 56 · 4.5%Very low 269 · 21.6%Low 349 · 28%Moderate 216 · 17.3%High 83 · 6.7%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Pharmacological interventions vs placebo
Depression: meeting study criteria for depression at end of treatment (primary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.7 [0.55, 0.88]8 studies · 1025 participantsVery low
Non‐invasive brain stimulation vs sham non‐invasive brain stimulation and/or usual care
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
no estimate extracted8 studies · 505 participantsVery low
Psychological therapy vs usual care and/or attention control
Depression: meeting study criteria for depression at end of treatment (primary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.77 [0.62, 0.95]6 studies · 521 participantsVery low
Psychological therapy vs usual care and/or attention control
Depression: meeting study criteria for depression at end of · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.85 [0.59, 1.21]3 studies · 201 participantsVery low
Psychological therapy vs usual care and/or attention control
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.65 [0.26, 1.66]9 studies · 889 participantsVery low
Pharmacological interventions vs placebo
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.48 [0.32, 0.7]6 studies · 511 participantsVery low
Psychological therapy vs usual care and/or attention control
Adverse events: all ‐ central nervous system events (e.g. suicidal intentions) (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.87 [0.2, 3.9]2 studies · 126 participantsVery low
Psychological therapy vs usual care and/or attention control
Adverse events: all ‐ other events ‐ not listed above (e.g. fall, too ill) (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.62 [0.13, 3.09]3 studies · 254 participantsVery low
Pharmacological intervention and psychological therapy (combination) vs a pharmacological intervention and usual care or attention control (single)
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
no estimate extracted3 studies · 278 participantsVery low
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single)
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 0.95 [0.69, 1.3]3 studies · 392 participantsVery low
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single)
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
no estimate extracted12 studies · 1055 participantsVery low
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single)
Adverse events: death (secondary outcome) · people with depression after stroke
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane
RR 1.06 [0.27, 4.16]5 studies · 487 participantsVery low

Reviews 108